My Experience Learning about Autism

Afzal N , Murch S , Thirrupathy K , Berger L , Fagbemi A , Heuschkel R . Constipation with acquired megarectum in children with autism. Pediatrics. 2003; 112(4): 939–42.

D'Eufemia P , Celli M , Finocchiaro R Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996; 85(9): 1076–9.

Bolte ER . Autism and Clostridium tetani. Med Hypotheses. 1998; 51(2):133–44.

Horvath K , Papadimitriou JC , Rabsztyn A , Drachenberg C , Tildon JT . Gastrointestinal abnormalities in children with autistic disorder. J Pediatr. 1999; 135(5): 559–63.

Furlano RI , Anthony A , Day R , Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr. 2001; 138(3):366–72.

Finegold SM , Molitoris D , Song Y Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis. 2002; 35(Suppl 1): S6–16.

Horvath K , Perman JA . Autistic disorder and gastrointestinal disease. Curr Opin Pediatr. 2002; 14(5): 583–7.

Jyonouchi H , Sun S , Itokazu N . Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology. 2002; 46(2): 76–84.

Torrente F , Ashwood P , Day R Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry. 2002; 7(4): 375–82, 334.

Vojdani A , Campbell AW , Anyanwu E , Kashanian A , Bock K , Vojdani E . Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol. 2002; 129(1-2): 168–77.

Ashwood P , Anthony A , Pellicer AA , Torrente F , Walker-Smith JA , Wakefield AJ . Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol. 2003; 23(6): 504–17.

Molloy CA , Manning-Courtney P . Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism. 2003; 7(2): 165–71.

O'Banion D , Armstrong B , Cummings RA , Stange J . Disruptive behavior: a dietary approach. J Autism Child Schizophr. 1978; 8(3): 325–37.

Bird BL , Russo DC , Cataldo MF . Considerations in the analysis and treatment of dietary effects on behavior: a case study. J Autism Child Schizophr. 1977; 7(4): 373–82.

Reichelt KL , Ekrem , Scott H . Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion. J Appl Nutr. 1990; 42: 1–11.

Knivsberg AM , Reichelt KL , Nodland M Autistic symptoms and diet: a follow-up study. Scand J Ed Res. 1995; 39: 223–36.

Whiteley P , Jacqui R , Savery D , Shattock P . A gluten-free diet as an intervention for autism and associated spectrum disorders: preliminary findings. Autism. 1999; 3(1): 45.

Blades M . Autism: an interesting dietary case history. Nutr Food Sci. 2000; 30(3): 137–40.

Cade R , Privette M , Fegly N Autism and schizophrenia: intestinal disorders. Nutr Neurosci. 2000; 2: 57–72.

Knivsberg AM , Reichelt KL , N⊘dland M . Reports on dietary intervention in autistic disorders. Nutr Neurosci. 2001; 4(1): 25–37.

Lucarelli S , Frediani T , Zingoni AM Food allergy and infantile autism. Panminerva Med. 1995; 37(3): 137–41.

Kidd PM . Autism, an extreme challenge to integrative medicine. Part II: medical management. Altern Med Rev. 2002; 7(6): 472–99.

Knivsberg AM , Reichelt KL , H⊘ien T , N⊘dland M . A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci. 2002; 5(4): 251–61.

Shattock P , Whiteley P . Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets. 2002; 6(2): 175–83.

Dolske MC , Spollen J , McKay S , Lancashire E , Tolbert L . A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry. 1993; 17(5): 765–74.

Rimland B , Callaway E , Dreyfus P . The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study. Am J Psychiatry. 1978 Apr; 135(4): 472–5.

Lelord G , Muh JP , Barthelemy C , Martineau J , Garreau B , Callaway E . Effects of pyridoxine and magnesium on autistic symptoms—initial observations. J Autism Dev Disord. 1981; 11(2): 219–30.

Paavonen EJ , Nieminen-von Wendt T , Vanhala R , Aronen ET , von Wendt L . Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder. J Child Adolesc Psychopharmacol. 2003; 13(1): 83–95.

Jan JE , O'Donnell ME . Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res. 1996; 21(4): 193–9.

Hayashi E . Effect of melatonin on sleep-wake rhythm: the sleep diary of an autistic male. Psychiatry Clin Neurosci. 2000; 54(3): 383–4.

Megson MN . Is autism a G-alpha protein defect reversible with natural vitamin A? Med Hypotheses. 2000; 54(6): 979–83.

McDougle CJ , Naylor ST , Cohen DJ , Aghajanian GK , Heninger GR , Price LH . Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry. 1996; 53(11): 993–1000.

Brudnak MA , Rimland B , Kerry RE Enzyme-based therapy for autism spectrum disorders—is it worth another look? Med Hypotheses. 2002; 58(5): 422–8.

Chez MG , Buchanan CP , Aimonovitch MC Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol. 2002 Nov; 17(11): 833–7.

Niederhofer H , Staffen W , Mair A . Galantamine may be effective in treating autistic disorder. BMJ. 2002; 325(7377): 1422.

Johnson SM , Hollander E . Evidence that eicosapentaenoic acid is effective in treating autism. J Clin Psychiatry. 2003; 64(7): 848–9.

Buie TM . Gastroesophageal reflux in children with autism: how do children present and can one test these children? J Pediatr Gastroenterol Nutr. 2005; 41(4): 505.

Elchaar GM , Maisch NM , Augusto LM , Wehring HJ . Efficacy and safety of naltrexone use in pediatric patients with autistic disorder. Ann Pharmacother. 2006; 40(6): 1086–95.

Rossignol DA , Rossignol LW . Hyperbaric oxygen therapy may improve symptoms in autistic children. Med Hypotheses. 2006; 67(2): 216–28.

Rossignol DA , Rossignol LW , James SJ , Melnyk S , Mumper E . The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study. BMC Pediatr. 2007; 7(1): 36.

Rossignol DA , Rossignol LW , Smith S Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatr. 2009; 9: 21.

Rossignol DA , Frye RE . Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol. 2011; 53(9): 783–92.

Rossignol DA . Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry. 2009; 21(4): 213–36.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.

Mulligan CK , Trauner DA . Incidence and behavioral correlates of epileptiform abnormalities in autism spectrum disorders. J Autism Dev Disord, 2013 Jul 20. [Epub ahead of print.]

Pennesi CM , Klein LC . Effectiveness of the gluten-free, casein-free diet for children diagnosed with autism spectrum disorder: based on parental report. Nutr Neurosci. 2012; 15(2): 85–91.

Whiteley P , Haracopos D , Knivsberg AM The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci. 2010; 13(2): 87–100.

Ramaekers VT , Weis J , Sequeira JM , Quadros EV , Blau N . Mitochondrial complex I encephalomyopathy and cerebral 5-methyltetrahydrofolate deficiency. Neuropediatrics. 2007; 38(4): 184–7.

Garcia-Cazorla A , Quadros EV , Nascimento A Mitochondrial diseases associated with cerebral folate deficiency. Neurology. 2008; 70(16): 1360–2.

Pérez-Dueñas B , Ormazábal A , Toma C Cerebral folate deficiency syndromes in childhood: clinical, analytical, and etiologic aspects. Arch Neurol. 2011; 68(5): 615–21.

Ramaekers VT , Hansen SI , Holm J Reduced folate transport to the CNS in female Rett patients. Neurology. 2003; 61(4): 506–15.

Ramaekers VT , Sequeira JM , Artuch R Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome. Neuropediatrics. 2007; 38(4): 179–83.

Ramaekers VT , Blau N . Cerebral folate deficiency. Dev Med Child Neurol. 2004; 46(12): 843–51.

Ramaekers VT , Rothenberg SP , Sequeira JM Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med. 2005; 352(19): 1985–91.

Moretti P , Peters SU , Del Gaudio D Brief report: autistic symptoms, developmental regression, mental retardation, epilepsy, and dyskinesias in CNS folate deficiency. J Autism Dev Disord. 2008; 38(6): 1170–7.

Ramaekers VT , Blau N , Sequeira JM , Nassogne MC , Quadros EV . Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics. 2007; 38(6): 276–81.

Ramaekers VT , Sequeira JM , Blau N , Quadros EV . A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome. Dev Med Child Neurol. 2008; 50(5): 346–52.

Shoffner J , Hyams L , Langley GN Fever plus mitochondrial disease could be risk factors for autistic regression. J Child Neurol. 2010; 25(4): 429–34.

Moretti P , Sahoo T , Hyland K Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology. 2005; 64(6): 1088–90.

Ramaekers VT , Quadros EV , Sequeira JM . Role of folate receptor autoantibodies in infantile autism. Mol Psychiatry. 2013 Mar; 18(3): 270–1.

Frye RE , Sequeira JM , Quadros EV , James SJ , Rossignol DA . Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry. 2013; 18: 369–81.

Rossignol DA , Frye RE . Folate receptor alpha autoimmunity and cerebral folate deficiency in autism spectrum disorders. J Ped Biochem. 2012; 2(4): 263–71.

Frye RE , Rossignol DA . Metabolic disorders and abnormalities associated with autism spectrum disorder. J Ped Biochem. 2012; 2(4): 181–91.

Rossignol DA , Bradstreet JJ . Evidence of mitochondrial dysfunction in autism and implications for treatment. Am J Biochem Biotech. 2008; 4(2): 208–17.

Rossignol DA , Frye RE . Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2012; 17(3): 290–314.

Frye RE , Rossignol DA . Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res. 2011; 69(5 Pt 2):41R–7R.

Frye RE , Rossignol DA . Treatments for mitochondrial dysfunction associated with autism spectrum disorders. J Ped Biochem. 2012; 2(4): 241–9.

Rossignol DA , Frye RE . A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2012; 17(4): 389–401.

Frye RE , Casanova M , Brown GL A consensus statement from the Elias Tembenis seizure think tanks. Autism Sci Dig, 2012; 5: 4–10.

Zappella M . Autistic regression with and without EEG abnormalities followed by favourable outcome. Brain Dev. 2010; 32(9): 739–45.

Helt M , Kelley E , Kinsbourne M Can children with autism recover? If so, how? Neuropsychol Rev. 2008; 18(4): 339–66.

O'Hara NH , Szakacs GM . The recovery of a child with autism spectrum disorder through biomedical interventions. Altern Ther Health Med. 2008; 14(6): 42–4.

Sitholey P , Agarwal V , Pargaonkar A . Rapid and spontaneous recovery in autistic disorder. Indian J Psychiatry. 2009; 51(3): 209–11.